Physiomics (LON:PYC) Shares Down 9.2% – Should You Sell?

Physiomics Plc (LON:PYCGet Free Report) traded down 9.2% during mid-day trading on Wednesday . The company traded as low as GBX 0.95 ($0.01) and last traded at GBX 0.95 ($0.01). 1,137,122 shares were traded during mid-day trading, a decline of 84% from the average session volume of 7,175,730 shares. The stock had previously closed at GBX 1.05 ($0.01).

Physiomics Price Performance

The stock’s fifty day moving average price is GBX 0.83 and its 200-day moving average price is GBX 0.74. The company has a market capitalization of £1.83 million, a price-to-earnings ratio of -13.83 and a beta of 1.69.

Physiomics Company Profile

(Get Free Report)

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.

Further Reading

Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.